I have access to Pharmaprojects. I will check the progress of the drug and post on Wednesday when I am in the office. In terms of figuring out where the clin trials are being conducted, check out http://www.centerwatch.com. While the candidate drug names are usually not mentioned, if you look in the right category, you can usually figure out what is going on.
Finally, a general comment about narcotic analgesics. The potential of a product can be limited if the product is found to have addictive properties. Look at what is happening to ULTRAM, (a J&J drug) and DURACT, (a Novartis drug). If they go on restrictive schedules, then the product potential goes down considerably. I should note that I do not know ANYTHING about the properties of the Abbott drug to know what class of products it falls into, and anything about its mechanism of action.
CW, thank you for the link to that neat site! I've sent away for their New Therapies newsletter. Such a deal! Unfortunaely, it's not too helpful in locating the ABT-594 test location. Seems they only list domestic trials while ABT-594 is being tested in Britain I believe. Hope you can find it in Pharmaprojects. Regards, Dragonfly.